What's breaking now, across thousands of outlets.
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrative drug launch.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Building the conditions for young people to thrive.
Delhi reported 138 new H1N1 cases, totaling 2,446 this year. Health Minister Pankaj Singh emphasised that patients generally show mild symptoms and there’s ‘no need for panic’, ensuring readiness for…
The companies would agree to align prices on outpatient drugs for state Medicaid programs with what they charge in foreign countries
It can take years for someone to be diagnosed with endometriosis. This can mean ongoing pain, repeated appointments, uncertainty and delayed treatment.
Cell therapy manufacturing startup Cellares is defending itself against Bristol Myers Squibb after the drugmaker pulled out of a contract claiming Cellares’ commercial manufacturing technology was not…
(MedPage Today) -- For opioid overdose survivors, starting methadone was associated with a reduced risk of death during the subsequent year compared with starting buprenorphine-naloxone, a…
